Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Recalcitrance of bacterial vaginosis among herpes-simplex-virus-type-2-seropositive women.

Stoner KA, Reighard SD, Vicetti Miguel RD, Landsittel D, Cosentino LA, Kant JA, Cherpes TL.

J Obstet Gynaecol Res. 2012 Jan;38(1):77-83. doi: 10.1111/j.1447-0756.2011.01697.x. Epub 2011 Dec 5.

2.

Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.

Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL.

Clin Infect Dis. 2005 May 15;40(10):1422-8. Epub 2005 Mar 29.

PMID:
15844064
4.

Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.

Recine N, Palma E, Domenici L, Giorgini M, Imperiale L, Sassu C, Musella A, Marchetti C, Muzii L, Benedetti Panici P.

Arch Gynecol Obstet. 2016 Jan;293(1):101-7. doi: 10.1007/s00404-015-3810-2. Epub 2015 Jul 5.

PMID:
26142892
5.

Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.

Baisley K, Changalucha J, Weiss HA, Mugeye K, Everett D, Hambleton I, Hay P, Ross D, Tanton C, Chirwa T, Hayes R, Watson-Jones D.

Sex Transm Infect. 2009 Sep;85(5):370-5. doi: 10.1136/sti.2008.035543. Epub 2009 May 26.

6.

Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis.

Masese L, Baeten JM, Richardson BA, Bukusi E, John-Stewart G, Jaoko W, Shafi J, Kiarie J, McClelland RS.

J Infect Dis. 2014 Apr 1;209(7):1023-7. doi: 10.1093/infdis/jit634. Epub 2013 Nov 22.

7.

Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.

Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA.

PLoS Med. 2012;9(6):e1001251. doi: 10.1371/journal.pmed.1001251. Epub 2012 Jun 26.

8.

Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.

Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S.

BJOG. 2009 Sep;116(10):1315-24. doi: 10.1111/j.1471-0528.2009.02237.x. Epub 2009 Jun 17.

9.

[Treatment of bacterial vaginosis with high dosage metronidazole and lactic acid].

Andreeva P, Slavchev B, Kovachev S, Nacheva A, Vacheva R.

Akush Ginekol (Sofiia). 2002;41(5):36-9. Bulgarian.

PMID:
12440337
10.

Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.

Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI.

J Infect Dis. 2009 Oct 1;200(7):1088-95. doi: 10.1086/605645.

11.

Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora.

Cherpes TL, Meyn LA, Krohn MA, Hillier SL.

Sex Transm Dis. 2003 May;30(5):405-10.

PMID:
12916131
12.

Treatment considerations for bacterial vaginosis and the risk of recurrence.

Chen JY, Tian H, Beigi RH.

J Womens Health (Larchmt). 2009 Dec;18(12):1997-2004. doi: 10.1089/jwh.2008.1088.

PMID:
20044862
13.

High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK.

J Infect Dis. 2006 Jun 1;193(11):1478-86. Epub 2006 Apr 26.

PMID:
16652274
14.

Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model.

Slade J, Hall JV, Kintner J, Schoborg RV.

PLoS One. 2016 Jan 4;11(1):e0146186. doi: 10.1371/journal.pone.0146186. eCollection 2016.

15.

Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women.

Marrazzo JM, Thomas KK, Fiedler TL, Ringwood K, Fredricks DN.

Ann Intern Med. 2008 Jul 1;149(1):20-8.

16.

Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies.

Nagot N, Ouedraogo A, Defer MC, Vallo R, Mayaud P, Van de Perre P.

Sex Transm Infect. 2007 Aug;83(5):365-8. Epub 2007 May 10.

17.

Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.

Crespi CM, Cumberland WG, Wald A, Corey L, Blower S.

Sex Transm Infect. 2007 Aug;83(5):359-64. Epub 2007 May 2.

18.

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.

Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J.

Lancet. 1997 Aug 23;350(9077):546-50. Erratum in: Lancet 1997 Oct 4;350(9083):1036.

PMID:
9284776
19.

Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India.

Madhivanan P, Krupp K, Chandrasekaran V, Karat C, Arun A, Cohen CR, Reingold AL, Klausner JD.

Indian J Med Microbiol. 2008 Apr-Jun;26(2):132-7.

20.

Supplemental Content

Support Center